Analysts Set Expectations for Synergy CHC FY2025 Earnings

Synergy CHC Corp. (NASDAQ:SNYR) – Analysts at Roth Capital reduced their FY2025 earnings estimates for shares of Synergy CHC in a research report issued to clients and investors on Friday, August 15th. Roth Capital analyst S. Mcgowan now expects that the company will post earnings per share of $0.41 for the year, down from their prior estimate of $0.48. The consensus estimate for Synergy CHC’s current full-year earnings is $0.36 per share. Roth Capital also issued estimates for Synergy CHC’s Q4 2025 earnings at $0.13 EPS, Q4 2026 earnings at $0.18 EPS and FY2027 earnings at $1.02 EPS.

Separately, Wall Street Zen upgraded shares of Synergy CHC to a “buy” rating in a research report on Saturday, June 21st.

Synergy CHC Price Performance

Synergy CHC stock opened at $3.43 on Monday. The stock has a market cap of $32.38 million and a P/E ratio of 9.03. Synergy CHC has a 1 year low of $1.19 and a 1 year high of $10.00. The firm’s 50 day moving average price is $3.14 and its 200-day moving average price is $2.40.

Synergy CHC (NASDAQ:SNYR) last released its earnings results on Thursday, August 14th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.09. Synergy CHC had a net margin of 10.02% and a negative return on equity of 16.92%. The company had revenue of $6.74 million for the quarter, compared to analysts’ expectations of $10.80 million.

Institutional Investors Weigh In On Synergy CHC

Several large investors have recently bought and sold shares of SNYR. Gratia Capital LLC purchased a new position in Synergy CHC during the fourth quarter worth $466,000. Paloma Partners Management Co purchased a new position in Synergy CHC during the fourth quarter worth $97,000. Sanders Morris Harris LLC boosted its stake in Synergy CHC by 3.4% during the first quarter. Sanders Morris Harris LLC now owns 391,485 shares of the company’s stock worth $920,000 after buying an additional 12,930 shares during the period. XTX Topco Ltd purchased a new position in Synergy CHC during the second quarter worth $57,000. Finally, Geode Capital Management LLC purchased a new position in Synergy CHC during the second quarter worth $29,000.

Insiders Place Their Bets

In other Synergy CHC news, CEO Jack Ross purchased 10,300 shares of Synergy CHC stock in a transaction that occurred on Friday, June 20th. The shares were bought at an average price of $2.60 per share, for a total transaction of $26,780.00. Following the completion of the transaction, the chief executive officer owned 395,057 shares of the company’s stock, valued at approximately $1,027,148.20. This trade represents a 2.68% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have acquired a total of 44,000 shares of company stock valued at $109,415 in the last quarter. Insiders own 56.60% of the company’s stock.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.